Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14148523 | 1.00 | F10 (1.00) | F10KCNH2 | |
| SCHEMBL1027621 | 0.92 | F10 (0.85) | F10KCNH2 | |
| SCHEMBL2251421 | 0.92 | F10 (0.85) | F10KCNH2 | |
| SCHEMBL2253925 | 0.92 | F10 (0.85) | F10KCNH2 | |
| SCHEMBL1026247 | 0.90 | F10 (0.81) | F10KCNH2 | |
| SCHEMBL1029728 | 0.90 | F10 (0.81) | F10KCNH2 | |
| SCHEMBL1027783 | 0.89 | F10 (0.80) | F10KCNH2 | |
| SCHEMBL4442235 | 0.87 | F10 (0.81) | F10KCNH2 | |
| SCHEMBL4453417 | 0.86 | F10 (1.00) | F10KCNH2 | |
| SCHEMBL4444216 | 0.86 | F10 (1.00) | F10KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7872141-B2 | Processes for the manufacture of a pyrrolidine-3,4-dicarboxamide derivative | HOFFMANN-LA ROCHE INC. (US) | 2011-01-18 | — | — | US | disclosed |
| US-7550487-B2 | Pyrrolidine-3,4-dicarboxamide derivatives | HOFFMANN-LA ROCHE INC. (US) | 2009-06-23 | — | — | US | disclosed |
| EP-1732918-B1 | NOVEL PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2008-11-12 | — | — | EP | disclosed |
| US-20080214826-A1 | PROCESSES FOR THE MANUFACTURE OF A PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVE | HOFFMANN-LA ROCHE, INC. | 2008-09-04 | — | — | US | disclosed |
| US-20080214826-A1 | PROCESSES FOR THE MANUFACTURE OF A PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVE | HOFFMANN-LA ROCHE, INC. | 2008-09-04 | — | — | US | disclosed |
| EP-1732918-A1 | NOVEL PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2006-12-20 | — | — | EP | disclosed |
| WO-2005092881-A1 | NOVEL PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2005-10-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214826-A1 | PROCESSES FOR THE MANUFACTURE OF A PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVE | ALDH18A1, CPS1, DHPS | F10 2376/4885KCNH2 1869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.